[Immunohistochemical assessment of HER2 expression in gastric cancer. A clinicopathologic study of 93 cases].

Background: Gastric cancer in Mexico is ranked third in both males and females. Most patients present clinically with advanced disease and treatment options are sparse. HER2 overexpression in gastric cancer is related to poor outcome.